help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boyan, B. D.
Right arrow Articles by Schwartz, Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boyan, B. D.
Right arrow Articles by Schwartz, Z.
Endocrinology Vol. 144, No. 5 1812-1824
Copyright © 2003 by The Endocrine Society

Estrogen-Dependent Rapid Activation of Protein Kinase C in Estrogen Receptor-Positive MCF-7 Breast Cancer Cells and Estrogen Receptor-Negative HCC38 Cells Is Membrane-Mediated and Inhibited by Tamoxifen

B. D. Boyan, V. L. Sylvia, T. Frambach, C. H. Lohmann, J. Dietl, D. D. Dean and Z. Schwartz

Wallace H. Coulter Department of Biomedical Engineering (B.D.B., Z.S.), Georgia Institute of Technology, Atlanta, Georgia 30332; Departments of Periodontics (Z.S.) and Orthopaedics (V.L.S., D.D.D.), University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229; Department of Gynecology (T.F., J.D.), University of Würzburg, 97070 Würzburg, Germany; Department of Orthopedics (C.H.L.), University of Eppendorf, 20255 Hamburg, Germany; and Department of Periodontics (Z.S.), Hebrew University Hadassah, Jerusalem 91120, Israel

Address all correspondence and requests for reprints to: Barbara D. Boyan, Ph.D., Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University, Georgia Institute of Technology, 315 Ferst Drive NW, Atlanta, Georgia 30332. E-mail: Barbara.Boyan{at}bme.gatech.edu.

We examined protein kinase C (PKC) in the regulation of breast cancer cells by estrogen. Estrogen receptor (ER)- positive (+) MCF-7 and ER-negative (-) HCC38 cells were treated with 17ß-estradiol (E2) or E2-BSA, which cannot enter the cell. E2 and E2-BSA rapidly increased PKC-{alpha} in both cells via phosphatidylinositol-dependent phospholipase C and G protein, but not phospholipase A2 or arachidonic acid. In MCF-7 cells, E2 and E2-BSA had comparable effects, maximal at 90 min. In HCC38 cells, PKC was maximal at 9 min, with E2-BSA more than E2. Tamoxifen blocked estrogen-dependent PKC in MCF-7 cells and reduced it in HCC38 cells. ER-antagonist ICI 182780, ER-agonist diethylstilbestrol, and antibodies to ER{alpha} and ERß had no effect. E2 stimulated [3H]thymidine incorporation in MCF-7 only; E2-BSA had no effect. Tamoxifen did not alter E2-dependent increases in MCF-7 cells, whereas ICI 182780 reduced DNA synthesis in control and E2-treated cultures. PKC activity was positively correlated with tumor severity in 133 breast cancer specimens and was greater in ER(-) tumors. Tamoxifen treatment reduced recurrence, and recurrent tumors had higher PKC activity. This indicates that E2 rapidly increases PKC activity via membrane pathways not involving ER{alpha} or ERß and suggests that tamoxifen works by reducing PKC activity through non-ER{alpha}/ERß-dependent mechanisms.




This article has been cited by other articles:


Home page
J EndocrinolHome page
C. K M Ho, J. Nanda, K. E Chapman, and F. K Habib
Oestrogen and benign prostatic hyperplasia: effects on stromal cell proliferation and local formation from androgen
J. Endocrinol., June 1, 2008; 197(3): 483 - 491.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Zheng, A. Kallio, and P. Harkonen
Tamoxifen-Induced Rapid Death of MCF-7 Breast Cancer Cells Is Mediated via Extracellularly Signal-Regulated Kinase Signaling and Can Be Abrogated by Estrogen
Endocrinology, June 1, 2007; 148(6): 2764 - 2777.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
N. Vasudevan and D. W. Pfaff
Membrane-Initiated Actions of Estrogens in Neuroendocrinology: Emerging Principles
Endocr. Rev., February 1, 2007; 28(1): 1 - 19.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. L. Temple and S. Wray
Bovine Serum Albumin-Estrogen Compounds Differentially Alter Gonadotropin-Releasing Hormone-1 Neuronal Activity
Endocrinology, February 1, 2005; 146(2): 558 - 563.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
I. S. Nethrapalli, A. A. Tinnikov, V. Krishnan, C. D. Lei, and C. D. Toran-Allerand
Estrogen Activates Mitogen-Activated Protein Kinase in Native, Nontransfected CHO-K1, COS-7, and RAT2 Fibroblast Cell Lines
Endocrinology, January 1, 2005; 146(1): 56 - 63.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
I. M. Abraham, M. G. Todman, K. S. Korach, and A. E. Herbison
Critical in Vivo Roles for Classical Estrogen Receptors in Rapid Estrogen Actions on Intracellular Signaling in Mouse Brain
Endocrinology, July 1, 2004; 145(7): 3055 - 3061.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society